FDA Inspection 1117002 - Aspire Houston Fertility Institute - February 06, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Aspire Houston Fertility Institute, with an inspection on February 6, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Aspire Houston Fertility Institute
Inspection Date: February 6, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · f08b4d81-62e3-4994-9519-d1b7e9c8baba